mBio Diagnostics, Inc. — Form D

mBio Diagnostics, Inc. of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-03. The offering totals $9.0M, of which $6.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Michael ChangDirectorSingapore, U0
Andrew DrenickDirectorBoulder, CO
Christopher MyattDirectorBoulder, CO
Judith O'BrienDirectorSan Leandro, CA
Robert SilvermanDirectorGreenville, SC
Nick TraggisDirectorDenver, CO
Nick TraggisExecutive OfficerDenver, CO
Milton ChangDirectorBoullder, CO
Christopher MyattExecutive OfficerBoulder, CO
Chris MyattDirectorBOULDER, CO
Chris MyattExecutive OfficerBOULDER, CO
Sarah C HatcherExecutive OfficerBoulder, CO
Michael J LochhaedExecutive OfficerBoulder, CO
Robert J SilvermanDirectorBoulder, CO
Michael J LochheadExecutive OfficerBoulder, CO
Christopher J MyattDirectorBoulder, CO
Christopher J MyattExecutive OfficerBoulder, CO
Milton J ChangDirectorBoulder, CO
Sarah J HatcherExecutive OfficerBoulder, CO
ROBERT C SILVERMANDirectorBOULDER, CO
MICHAEL C LOCHHEADExecutive OfficerBOULDER, CO
Michael LochheadExecutive OfficerBoulder, CO
Sarah HatcherExecutive OfficerBoulder, CO

Other filings by this issuer (14)

FiledFormOfferingSold
2021-03-22D$4.0M$1.7M
2021-02-02D$10.0M$10.0M
2020-08-03D/A$11.0M$6.1M
2020-07-31D$11.0M$6.1M
2020-03-24D/A$3.0M$1.6M
2020-03-24D/A$3.0M$1.6M
2020-02-10D$2.0M$550K
2018-08-22D$6.4M$5.2M
2018-05-21D$620K$620K
2018-05-21D$1.5M$1.1M
2016-08-24D$2.3M$563K
2015-05-21D$6.3M$6.3M
2012-09-05D$3.9M$3.9M
2011-01-05D$2.0M$2.0M

More